πŸ”¬ Pharmidex is proud to advance the frontiers of drug discovery πŸ”¬
June 23, 2025

With our cutting-edge in silico drug discovery capabilities πŸ‘‰ https://www.pharmidex.com/In-silico


Pharmidex   is committed to accelerating the development of novel therapies targeting GLP-1 receptors, a promising path in the fight against obesity and type 2 diabetes.

By combining our in silico expertise, including molecular docking, virtual screening and structure-based design, with our well-established in vivo obesity models, we offer a powerful, integrated platform to uncover and validate new therapeutic candidates more efficiently.


Whether you're a pharma company, CRO, biotech, or academic institution, Pharmidex is ready to collaborate and support your discovery efforts from computational predictions to real-world preclinical validation.


🀝 Let’s combine strengths and accelerate innovation in metabolic disease research to improve human health globally.


#DrugDiscovery #GLP1 #InSilico #Pharmidex #ObesityResearch #Diabetes #PreclinicalResearch #AIinDrugDiscovery #PharmidexInSilico #InVivoModels #GLP1Receptor

SMR Women’s Health Meeting
June 17, 2025
We’re excited to share that Janette Robertson (Business Development Manager) and Professor Mo Alavijeh (Managing Director) will attend the SMR Women’s Health Meeting at Friends House, London. They look forward to meeting attendees and discussing collaboration opportunities in drug discovery and development, especially in women’s health. πŸ“… More info: https://www.smr.org.uk/Meetings/20250617/ 🀝 Let’s connect in London!
June 16, 2025
πŸ‘‰ www.pharmidex.com/medical-device-testing-services With over 23 years of experience in preclinical R&D, we’re expanding our capabilities to support the development and regulatory testing of innovative medical devices from biocompatibility assessments to in vitro and in vivo efficacy models. This new service allows us to collaborate even more closely with biotech companies, CRO partners, academic innovators and medical device startups helping bring safe, effective and transformative technologies to patients faster. Whether you're exploring a novel implant, delivery system, or diagnostic platform, our team is ready to support you at every step with the same scientific integrity and agility that Pharmidex is known for. πŸ’‘ Let’s accelerate innovation, together.
June 11, 2025
Pharmidex team are delighted to participate in workshop on "Re-shaping UK life science commercialisation strategy" organised by The Research and Development Society on Wednesday 11th June, at Mereside, Alderley Park. If you are attending, please linkup with our colleague Mo Alavijeh who will be delighted to meet you. Jamie Phadke , Alderley Park #UKlifescience https://lnkd.in/e6uKsRcN
More Posts